This website is intended for Medical Professionals only. By using this site you confirm that you are a healthcare professional.

News
Keep it pumping Series - Episode 3       This is the third in a six-part series ... (20 Oct 2018)
Keep it pumping Series - Episode 2       This is the first in a six-part series ... (20 Oct 2018)
Keep it pumping Series - Episode 1 This is the first in a six-part series dealing with Heart ... (20 Oct 2018)
CHRONIC VENOUS DISEASE Log on to TheSynapse eLearning for a deeply insightful ... (20 Oct 2018)
Friday, 13 July 2018 22:12

Valsartan: Updated list of potentially impacted products Featured

Rate this item
(0 votes)

The Superintendent of Public Health has issued an updated list of products with the active substance valsartan that may be potentially impacted by the N-nitrosodimethylamine (NDMA) impurity.

 

 

 

It is important to note that treatment should not be stopped until the patient has been prescribed an alternative. The health risk of discontinuing this medicine is higher than any potential risk presented by the impurity. At present there is no evidence that the impurity in some stocks of valsartan has caused any harm to patients. Further updates will be provided as more information becomes available.

 

Read 283 times

TheSynapse e-Learning

0
0
0
0
0
0

Latest news

Highlights

  • Dermfest 2018

    Dermfest is fast approaching.

    Have you registered?

    If not click on the video to know more about this year's event. 

    Written on October 19, 2018 Read more...

Join

Connect with other Medical Professionals on fb in a closed facebook group

captcha  

Login

Template Settings

Theme Colors

Cyan Red Green Oranges Teal

Layout

Wide Boxed Framed Rounded
Patterns for Layour: Boxed, Framed, Rounded
Top
We use cookies to improve our website. By continuing to use this website, you are giving consent to cookies being used. More details…